BioCentury
ARTICLE | Clinical News

Zymafos palifosfamide: Phase III started

July 26, 2010 7:00 AM UTC

Ziopharm began the double-blind, placebo-controlled, international Phase III PICASSO 3 trial to evaluate doxorubicin with or without IV palifosfamide in 424 anthracycline-naïve patients. The company i...